Advanced search
Publication Cover
Hematology Volume 27, 2022 - Issue 1
Submit an article Journal homepage
2,364
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Association between serum calcium and in-hospital mortality in critical patients with multiple myeloma: a cohort study

Yafei MaoDepartment of Laboratory Medicine, The First Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-4822-8189
ORCID Icon,
Shumin ZhuDepartment of Laboratory Medicine, The First Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-4436-9224
ORCID Icon &
Yulan GengDepartment of Laboratory Medicine, The First Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7332-1791
ORCID Icon
Pages 795-801 | Published online: 12 Jul 2022

References

  • Dimopoulos MA, Moreau P, Terpos E, et al. Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(dagger). Ann Oncol. 2021;32:309–322. doi:10.1016/j.annonc.2020.11.014.
  • Thaw SS, Sahmoun A, Schwartz GG. Serum calcium, tumor size, and hormone receptor status in women with untreated breast cancer. Cancer Biol Ther. 2012;13:467–471. doi:10.4161/cbt.19606.
  • Schwartz GG, Tretli S, Vos L, et al. Prediagnostic serum calcium and albumin and ovarian cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort. Cancer Epidemiol. 2017;49:225–230. doi:10.1016/j.canep.2017.07.004.
  • Schwartz GG, Skinner HG. A prospective study of total and ionized serum calcium and time to fatal prostate cancer. Cancer Epidemiol Biomarkers Prev. 2012;21:1768–1773. doi:10.1158/1055-9965.EPI-12-0585.
  • Huang T, Zhou J, Wang J. Calcium and calcium-related proteins in endometrial cancer: opportunities for pharmacological intervention. Int J Biol Sci. 2022;18:1065–1078. doi:10.7150/ijbs.68591.
  • Christoulas D, Terpos E, Dimopoulos MA. Pathogenesis and management of myeloma bone disease. Expert Rev Hematol. 2009 Aug;2(4):385–398.
  • Roodman GD, Dougall WC. RANK ligand as a therapeutic target for bone metastases and multiple myeloma. Cancer Treat Rev. 2008;34:92–101. doi:10.1016/j.ctrv.2007.09.002.
  • Gordon AC, Oakervee HE, Kaya B, et al. Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: a prospective observational study of ward and intensive care unit based care. Anaesthesia. 2005;60:340–347. doi:10.1111/j.1365-2044.2005.04139.x.
  • Lloyd-Thomas AR, Wright I, Lister TA, et al. Prognosis of patients receiving intensive care for lifethreatening medical complications of haematological malignancy. Br Med J (Clin Res Ed). 1988;296:1025–1029. doi:10.1136/bmj.296.6628.1025.
  • Peters SG, Meadows III JA, Gracey DR. Outcome of respiratory failure in hematologic malignancy. Chest. 1988;94:99–102. doi:10.1378/chest.94.1.99.
  • Yau E, Rohatiner AZ, Lister TA, et al. Long term prognosis and quality of life following intensive care for life-threatening complications of haematological malignancy. Br J Cancer. 1991;64:938–942. doi:10.1038/bjc.1991.430.
  • Azoulay E, Recher C, Alberti C, et al. Changing use of intensive care for hematological patients. Intensive Care Med. 1999;25(12):1395–1401.
  • Diao X, Cai R, Luo J, et al. Prognostic factors for patients with multiple myeloma admitted to the intensive care unit. Hematology. 2020;25:433–437. doi:10.1080/16078454.2020.1845502.
  • Oyajobi BO. Multiple myeloma/hypercalcemia. Arthritis Res Ther. 2007;9(Suppl 1):S4, doi:10.1186/ar2168.
  • Goldberger AL, Amaral LA, Glass L, et al. PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation. 2000;101:E215–E220. doi:10.1161/01.cir.101.23.e215.
  • Johnson AE, Stone DJ, Celi LA, et al. The MIMIC Code Repository: enabling reproducibility in critical care research. J Am Med Inform Assoc. 2018 Jan 1;25(1):32–39.
  • Xiao Z, Gong R, Chen X, et al. Association between serum lactate dehydrogenase and 60-day mortality in Chinese Hakka patients with acute myeloid leukemia: A cohort study. J Clin Lab Anal. 2021 Dec;35(12):e24049, doi:10.1002/jcla.24049. Epub 2021 Oct 28. PMID: 34708888; PMCID: PMC8649362.
  • Cheng J, Zhang W, Zhao Y, et al. Association of serum calcium levels with renal impairment and all-cause death in Chinese patients with newly diagnosed multiple myeloma: a cross-sectional, longitudinal study. Nutr Metab (Lond). 2021;18:19, doi:10.1186/s12986-020-00525-0.
  • Maillet D, Montiel-Cervantes L, Padilla-González Y, et al. Serum calcium is an independent prognostic factor of overall survival in Mexican patients with multiple myeloma. Rev Invest Clin. 2012 Jan-Feb;64(1):17–24.
  • Haddadi A, Ledmani M, Gainier M, et al. Comparing the Apache II, Sofa, Lod, and SAPS II scores in patients who have developed a nosocomial infection. Bangladesh Crit Care J. 2014;2(1):4.
  • Choi JY, Jang JH, Lim YS, et al. Performance on the APACHE II, SAPS II, SOFA and the OHCA score of post-cardiac arrest patients treated with therapeutic hypothermia. Plos One. 2018;13:e0196197, doi:10.1371/journal.pone.0196197.
  • Cour M, Bresson D, Hernu R, et al. SOFA score to assess the severity of the post-cardiac arrest syndrome. Resuscitation. 2016;102:110–115. doi:10.1016/j.resuscitation.2016.03.001.
  • Hampshire PA, Welch CA, McCrossan LA, et al. Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care. 2009;13:R137, doi:10.1186/cc8016.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.